Figure 1: steroid Hormones |
Popular
biotransformations throughout history
have included
utilising yeast to convert glucose to ethanol and CO2, the use of lactic acid bacteria to make yoghurt and the employment of the
fungusAspergillus niger to make citric acid. More recent
biotransformation technologies, however, have become more sophisticated,
involving such procedures as the production of pharmaceuticals and the
development of methods to reduce environmental pollution.
Biotransformation
Technology in the Production of Steroid Hormones
Steroid hormones ( fig.1) are
important therapeutic drugs, as they assist in various metabolic functions in
the human body. Manufacturing these chemicals involves many steps and the costs
involved can be exorbitant. Recent use of micro fungi and bacteria to carry out
some of these steps has proved to be extremely efficient and cost effective.
Examples include using the fungus
Rhizopus arrhizus to convert progesterone to 11- hydroxy progesterone and
finally to cortisone (fig.2), which is an antiarthritic drug. In this process,
progesterone is added to a fermentation tank containing the fungus, which
hydroxylates the progesterone at the number 11 carbon atom in its steroid ring.
Such a hydroxylation step would
otherwise be laborious and expensive using synthetic methods alone. Further
chemical synthesis steps are then used to convert 11-hydroxy progesterone into
cortisone. The incorporation of biotransformation technology into this process
has reduced the cost of cortisone production in the U.S. by a factor of around
400.
Researchers at the Tehran University
of Medical Sciences have also investigated the biotransformation properties of
the fungus Nerospora crassa, which can transform the steroid hydrocortisone
into a pregnane and androstane derivative by removing the hydroxyl side chains
from the molecule. This has commercial potential, as drugs in this family are
used to treat endometriosis and other hormonal conditions, and can also act as
anti-inflammatory agents.
Biotransformation in the Production
of Antibiotics and Vitamin C
Biotransformation technologies are
not limited to the production of steroid derivatives. New, more effective
antibiotics, for instance, can be manufactured from existing ones using
microbe-mediated transformations. Examples of this include penicillin and
cephalosporins, which can be deacylated by microbes to produce semi-synthetic
varieties of the original antibiotics.
In addition, the bacterium
Acetobacter suboxydans can be used in the production of ascorbic acid (vitamin
C), by transforming D-sorbitol, a derivative of glucose, to L-sorbose.
L-sorbose is then chemically transformed to ascorbic acid.
Biotransformation
and the Environment
A study by Lai, Scrimshaw and Lester
(2002), has found that the algaChlorella vulgaris, can transform both
natural and synthetic oestrogens. The syntheric oestrogen, oestradiol valerate,
was shown to be transformed to oestradiol, and the natural oestrogens
oestradiol and oestrone were also converted to related compounds in the
presence of the alga.
This has environmental significance,
as it throws light on the ability of microbes to detoxify various pollutants
present in sewage and other runoff. Indeed, some macroalgae have been nicknamed
‘green liver’, as they have similar detoxifying enzymes as the human liver.
Other algal species are capable of transforming heavy metal and organic
pollutants.
Perhaps one of the more significant
recent discoveries in this area has been that of the hydrocarbonoclastic
bacteria, which can degrade alkanes as part of their metabolism. This shows
potential for the possible biodegradation of oil spills in marine environments.
Scientists looking for ways to reduce the recent Deepwater Horizon oil leak are
suggesting that naturally occurring bacteria from the Vibrio family are capable
of degrading some of the oil.
They are already adding fertiliser to
the oil that has reached the shore to promote the growth of these microbes. The
introduction of additional oil eating bacteria such as Alcanovirax borkumensis
is also being considered.
Other examples of such ‘bioremediation’
include using microbes to detoxify compounds present in pesticides and raw
sewage in both soil and water ecosystems. The US Geological Survey (USGS), for
instance, has been researching the biotransforming effects of microbes such as
the bacterium Dehalococcoides ethenogenes on chloroethenes, common contaminants
of groundwater systems. These microbes are able to convert chloroethanes to
safer,less chlorinated compounds.
Biotransformation
Companies and the Future
The Biotech company, Spi Bio is an
example of the commercial application of biotransformation technologies. This
organisation advertises services that include the production of metabolites by
bacteria, filamentous fungi and yeasts, which mimic the chemical pathways
present in the mammalian cytochrome system.
Biotransformation technologies have
obviously come a long way since the early use of yeasts and bacteria to make
bread, wine and yoghurt. With the millions of species of bacteria and fungi on
the earth the possibilities for utilising their biochemical pathways to our own
advantage are virtually endless.
References
Fathabad, Yahzdi, Faramarzi, and
Amini, 2006, ‘Biotransformation of Hydrocortisone by Neurospora crassa’ Journal
of Sciences, University of Tehran, sid.ir, accessed 4/6/2010
Lai, Scrimshaw and Lester, 2001,
'Biotransformation and Bioconcentration of Steroid Estrogens by Chlorella
vulgaris', Imperial College of Science, Technology and Medicine,
London, asm.org, accessed 3/6/2010
SPI BIO Bertin Group, 'Generating New
Chemical Entities Using Biotransformation Technology' spibio.com, accessed
4/6/2010
Figure 2: Cortisone |
USGS, 2008, Microbial Degradation of Chloroethenes in Groundwater systems, toxics.usgs.gov, accessed 2/6/2010